| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 3.73e-03 | 749 | 9 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.51e-03 | 230 | 9 | 2 | GO:0005516 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 8.05e-03 | 310 | 9 | 2 | GO:0030246 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.68e-04 | 52 | 8 | 2 | M14171 | |
| Coexpression | HAY_BONE_MARROW_CD34_POS_MKP | 1.15e-06 | 64 | 9 | 3 | M39187 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 1.17e-04 | 39 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.24e-04 | 40 | 9 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 2.09e-04 | 52 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 7.43e-04 | 98 | 9 | 2 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.30e-03 | 130 | 9 | 2 | gudmap_developingGonad_e12.5_ovary_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.38e-03 | 134 | 9 | 2 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 1.57e-03 | 143 | 9 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 1.77e-03 | 152 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 1.91e-03 | 158 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-06 | 156 | 9 | 3 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-06 | 157 | 9 | 3 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.73e-06 | 186 | 9 | 3 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 6.11e-06 | 190 | 9 | 3 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 191 | 9 | 3 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-04 | 128 | 9 | 2 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 2.94e-04 | 130 | 9 | 2 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 130 | 9 | 2 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-04 | 132 | 9 | 2 | 295980f70645ee2934145e9959c01f999044da3e | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.13e-04 | 134 | 9 | 2 | 1d6e74612fd91a2ef9d14bf77262b2d08e1052ca | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.27e-04 | 137 | 9 | 2 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-04 | 139 | 9 | 2 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 142 | 9 | 2 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 148 | 9 | 2 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 148 | 9 | 2 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-04 | 149 | 9 | 2 | 59aa1f2a5cbeba64c4529fb05f544db17fd8b188 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-04 | 149 | 9 | 2 | 1527cdd98a2734cbf8ce4c6170557280b71c55cb | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.91e-04 | 150 | 9 | 2 | 408b7c2c3a42f5455c8c26a83d9e366a1c8d5ecc | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 4.23e-04 | 156 | 9 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 4.23e-04 | 156 | 9 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-04 | 157 | 9 | 2 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.62e-04 | 163 | 9 | 2 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.62e-04 | 163 | 9 | 2 | 03b2ec226adffba3ce893f3d12e549c841e662fd | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.73e-04 | 165 | 9 | 2 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.73e-04 | 165 | 9 | 2 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 4.73e-04 | 165 | 9 | 2 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.73e-04 | 165 | 9 | 2 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 4.79e-04 | 166 | 9 | 2 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 4.79e-04 | 166 | 9 | 2 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 4.79e-04 | 166 | 9 | 2 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 4.85e-04 | 167 | 9 | 2 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.96e-04 | 169 | 9 | 2 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 4.96e-04 | 169 | 9 | 2 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 5.02e-04 | 170 | 9 | 2 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-04 | 170 | 9 | 2 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 5.02e-04 | 170 | 9 | 2 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 5.02e-04 | 170 | 9 | 2 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.02e-04 | 170 | 9 | 2 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 171 | 9 | 2 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 171 | 9 | 2 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 171 | 9 | 2 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 5.08e-04 | 171 | 9 | 2 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 5.14e-04 | 172 | 9 | 2 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 5.14e-04 | 172 | 9 | 2 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 5.14e-04 | 172 | 9 | 2 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.14e-04 | 172 | 9 | 2 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.14e-04 | 172 | 9 | 2 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.14e-04 | 172 | 9 | 2 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.26e-04 | 174 | 9 | 2 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.26e-04 | 174 | 9 | 2 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-04 | 174 | 9 | 2 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|normal_Lung / Location, Cell class and cell subclass | 5.38e-04 | 176 | 9 | 2 | f31d7234053085a82cf9d55aeedd1e04d34789c3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.44e-04 | 177 | 9 | 2 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | severe_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 5.44e-04 | 177 | 9 | 2 | 289f6aed6f054b04b01659434d8c8b467d1bf5dd | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 5.50e-04 | 178 | 9 | 2 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.50e-04 | 178 | 9 | 2 | cb9a446c145b1435cfe12a1d4568aed0924a6a20 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-04 | 179 | 9 | 2 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 5.56e-04 | 179 | 9 | 2 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-04 | 179 | 9 | 2 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-04 | 179 | 9 | 2 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-04 | 179 | 9 | 2 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 5.56e-04 | 179 | 9 | 2 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.63e-04 | 180 | 9 | 2 | 2694f5deaed551c53e74d8a9fbd41d3734bb9f37 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 5.63e-04 | 180 | 9 | 2 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.63e-04 | 180 | 9 | 2 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.63e-04 | 180 | 9 | 2 | ef0de602fc8ccfd32a06978ac0100afe0ce1beeb | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.69e-04 | 181 | 9 | 2 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.69e-04 | 181 | 9 | 2 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.69e-04 | 181 | 9 | 2 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | Healthy/Control-pDC|World / Disease group and Cell class | 5.75e-04 | 182 | 9 | 2 | 97e0eee10905f2cf2bebb09e474629fc224f4397 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.75e-04 | 182 | 9 | 2 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.81e-04 | 183 | 9 | 2 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.81e-04 | 183 | 9 | 2 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-04 | 183 | 9 | 2 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | wk_15-18-Hematologic-Myeloid-MEP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.88e-04 | 184 | 9 | 2 | 19d61d0ab038b7e729e13a46f88b8cf31759485d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-04 | 184 | 9 | 2 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.88e-04 | 184 | 9 | 2 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.88e-04 | 184 | 9 | 2 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 5.88e-04 | 184 | 9 | 2 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | megakaryocytic|World / Lineage and Cell class | 5.88e-04 | 184 | 9 | 2 | b1c630ca2189d9d49402a5621b57618976fbea5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-04 | 184 | 9 | 2 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-04 | 184 | 9 | 2 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 5.94e-04 | 185 | 9 | 2 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | Control-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 5.94e-04 | 185 | 9 | 2 | 0af540323c0113203ba6c1a4cb32d2fb9cf79d39 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.94e-04 | 185 | 9 | 2 | 9bff336510c80cd762b4e41b4570475033e709ca | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.94e-04 | 185 | 9 | 2 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.94e-04 | 185 | 9 | 2 | 452d49c7835a4d55e41caefa44dac5cab30e7ced | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 5.94e-04 | 185 | 9 | 2 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.94e-04 | 185 | 9 | 2 | 67ac5c2bacdbdcb40ee65c44da55b3f597b410ee | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.94e-04 | 185 | 9 | 2 | 53f5136ee1bd101dd5ac8a2c9e63b0c3b987657e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.00e-04 | 186 | 9 | 2 | 9e2e8e2c3de711734cdb4775bafb0757b4db97b1 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.00e-04 | 186 | 9 | 2 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.00e-04 | 186 | 9 | 2 | 8fbf5cb31192066b4c202f80baf6d7f2bdefedb9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Hematopoietic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.00e-04 | 186 | 9 | 2 | 1dfd3fc4012bf0254adfa1f5eddadc9b6107455b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Hematopoietic-Megakaryocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.00e-04 | 186 | 9 | 2 | 49d23c985b2f5e16790f4d7ccf81ef7b794c0877 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 6.00e-04 | 186 | 9 | 2 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| Drug | AC1L1BPL | 9.53e-06 | 11 | 10 | 2 | CID000001548 | |
| Drug | AC1L1I3V | 5.18e-05 | 25 | 10 | 2 | CID000004411 | |
| Drug | NSC406942 | 7.00e-05 | 565 | 10 | 4 | CID000001115 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.32e-05 | 195 | 9 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | Parkinson disease | 1.02e-04 | 321 | 9 | 3 | MONDO_0005180 | |
| Disease | diverticular disease | 2.21e-03 | 236 | 9 | 2 | EFO_0009959 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AMKQWEYNEKLAFHM | 226 | Q86YW9 | |
| DDFKSHVYMAWNIPM | 406 | Q9HCQ5 | |
| MYDEKAHEWKSLAPM | 361 | Q9P2N7 | |
| PMYEEFRKMWDYFHS | 716 | O14638 | |
| AEMMAENYHNIWAKK | 2841 | Q92736 | |
| EKKNHPDFMIDWMYF | 71 | Q9H2U6 | |
| WYEPMQKFMLIKHFD | 651 | Q9Y4K4 | |
| FYNEKMKFDGLWIDM | 1381 | P14410 | |
| KWENDKDMTMSFHYI | 171 | Q6H3X3 | |
| VMWHLFAQDMKYALE | 1006 | O14795 |